TRVN Trevena Inc

Trevena Inc is a clinical stage biopharmaceutical company. It discovers, develops and commercialize therapeutics that use a novel approach to target G protein coupled receptors.

$1.88  -0.02 (-1.05%)
As of 06/22/2021 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/31/2014
Outstanding shares:  163,593,457
Average volume:  2,079,592
Market cap:   $312,463,503
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    89532E109
ISIN:        US89532E1091
Sedol:      BGDW0N7
Valuation   (See tab for details)
PE ratio:   -11.40
PB ratio:   3.13
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy